ARCHIMED’s Acquisition of FIM Medical

Dechert advised ARCHIMED on the deal. ARCHIMED, a leading international private equity player specializing in the healthcare sector, has acquired FIM Medical, a prominent player in...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Graham Partners’ Acquisition of Taoglas

Dechert represented Graham Partners in the transaction. Graham Partners, a private investment firm targeting technology-driven advanced manufacturing companies, executed its acquisition of Taoglas Group Holdings Ltd.  Graham...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Havea’s Acquisition of Biocyte

Dechert advised Havea. PwC Société d’Avocats carried out tax due diligence on behalf of Havea Group. Havea Group has announced that it has entered into exclusive negotiations...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Chiesi Farmaceutici’s Acquisition of Amryt Pharma Plc

Dechert advised Chiesi Farmaceutici S.p.A. Gide Loyrette Nouel represented BNP Paribas. Amryt Pharma was advised by Cooley. Italian pharmaceutical company Chiesi Farmaceutici has signed a definitive agreement to acquire Amryt Pharma in...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here